Alveron Pharma

About:

Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.

Website: http://www.alveron.com/

Top Investors: Thuja Capital, Netherlands Enterprise Agency, OostNL, Waterman Ventures

Description:

Alveron Pharma develops treatment for hemorrhagic stroke, a severe unmet medical need. Alveron’s drug OKL-1111 strongly reduces hematoma expansion in a mouse model of intracranial hemorrhage. As an injection solution that is ready to use, OKL-1111 is being developed to do away with a laborious pre-treatment process.